Showing results (381-390 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|May 4, 2023
Comparative analysis of immune checkpoint inhibitors in first-line treatment of esophageal squamous cell carcinoma: a network meta-analysisYangfeng Zhang, Chunhui Li, Kunpeng Du, et al.Immunotherapy|May 4, 2023
Short-course treatment after complete response to pembrolizumab in metastatic urothelial bladder cancer: a case seriesHenri Plais, Clément Dumont, Hélène Gauthier, et al.Immunotherapy|August 21, 2020
Camrelizumab plus apatinib successfully treated a patient with advanced esophageal squamous cell carcinomaZheng Yan, Zhi-Hua Yao, Shu-Na Yao, et al.Immunotherapy|March 29, 2021
Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysisFausto Petrelli, Roberto Ferrara, Diego Signorelli, et al.Immunotherapy|August 19, 2020
Neurological adverse events following CAR T-cell therapy: a real-world analysisAjeet Gajra, Marjorie E Zettler, Eli G Phillips, et al.Immunotherapy|April 3, 2023
Tofacitinib experience in patients with enteropathic arthritisPınar Akyüz Dağlı, Abdulsamet Erden, Serdar Can Güven, et al.Immunotherapy|April 3, 2023
Simultaneous inhibition of PD-1 and LAG-3: the future of immunotherapy?Sasha-Jane Abi-Aad, Joseph Zouein, Antoine Chartouni, et al.Immunotherapy|April 3, 2023
Targeting PD-1/PD-L1 in biliary tract cancer: role and available dataReem D Mahmood, Kathryn Graham, Jack Gleeson, et al.Immunotherapy|April 6, 2023
Cost-effectiveness of adjuvant atezolizumab for patients with stage II-IIIA PD-L1+ non-small-cell lung cancerMillie Das, Sarika Ogale, Nick Jovanoski, et al.Pageof 188